Preventive effect of recombinant human lactoferrin on lipopolysaccharide- induced preterm delivery in mice

Acta Obstetricia et Gynecologica Scandinavica

Volumn 83, Issue 11, 2004, Pages 1035-1038

  Sasaki, Yasushi ^a   Otsuki, Katsufumi ^a   Hasegawa, Akitoshi ^a   Sawada, Maki ^a   Chiba, Hiroshi ^a   Negishi, Momoko ^a   Nagatsuka, Masaaki ^a   Okai, Takashi ^a  

^a SHOWA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Interleukin 6; Lactoferrin; Lipopolysaccharide; Preterm delivery

Indexed keywords

INTERLEUKIN 6; LACTOFERRICIN; LIPOPOLYSACCHARIDE; RECOMBINANT LACTOFERRICIN; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; FEMALE; GESTATIONAL AGE; NONHUMAN; PREMATURE LABOR; PRIORITY JOURNAL; PROLONGED PREGNANCY; PROTEIN DETERMINATION;

ANIMALS; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; INJECTIONS, INTRAPERITONEAL; INTERLEUKIN-6; LACTOFERRIN; LIPOPOLYSACCHARIDES; MICE; MICE, INBRED C3H; OBSTETRIC LABOR, PREMATURE; PREGNANCY; RECOMBINANT PROTEINS;

EID: 7644241949     PISSN: 00016349     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0001-6349.2004.00587.x     Document Type: Article

References (23)

1. Romero R, Mazor M, Wu YK, Sirtori M, Oyarzun E, Mitchell MD et al. Infection in the pathogenesis of preterm labor. Semin Perinatol 1988; 12: 262-79.
2. Drife J. Infection and preterm birth. Br J Obstet Gynaecol 1989; 96: 1128-32.
3. Niemela A, Kulomaa M, Vija P, Tuohimaa P, Saarikoski S. Lactoferrin in human amniotic fluid. Hum Reprod 1989; 4: 99-101.
4. Otsuki K, Yoda A, Hirose K, Shimizu Y, Saito H, Yanaihara T. Salivary lactoferrin in neonates with chorioamnionitis. Showa Univ J Med Sci 1997; 9: 39-44.
5. Birgens HS. The interaction of lactoferrin with human monocytes. Dan Med Bull 1991; 38: 244-52.
6. Otsuki K, Yoda A, Saito H, Mitsuhashi Y, Toma Y, Shimizu Y et al. Amniotic fluid lactoferrin in intrauterine infection. Placenta 1999; 20: 175-9.
7. Mitsuhashi Y, Otsuki K, Yoda A, Shimizu Y, Saito H, Yanaihara T. Effect of lactoferrin on lipopolysaccharide (LPS) induced preterm delivery in mice. Acta Obstet Gynecol Scand 2000; 79: 355-8.
8. Kaga N, Katsuki Y, Obata M, Shibutani Y. Repeated administration of low-dose lipopolysaccharide induces preterm delivery in mice: a model for human preterm parturition and for assessment of the therapeutic ability of drugs against preterm delivery. Am J Obstet Gynecol 1996; 174: 754-9.
9. Kaga N, Katsuki Y, Futamura Y, Obata M, Shibutani Y. Role of urinary trypsin inhibitor in the maintenance of pregnancy in mice. Obstet Gynecol 1996; 88: 872-82.
10. Kaga N, Katsuki Y, Kajikawa S, Shibutani Y. Preventive effect of ritodrine hydrochloride and/or urinary trypsin inhibitor against lipopolysaccharide-induced preterm delivery in mice. Acta Obstet Gynecol Scand 1997; 76: 811-6.
11. Arias F, Rodriquez L, Rayne S, Kraus F. Maternal placental vasculopathy and injection: two distinct subgroups among patients with preterm labor and preterm ruptured membranes. Am J Obstet Gynecol 1993; 168: 585-91.
12. Duff P, Kopelman J. Subclinical intra-amniotic infection in asymptomatic patients with refractory preterm labor. Obstet Gynecol 1987; 69: 756-9.
13. Romero R, Sirtori M, Oyarzum E, Avila C, Mazor M, Callaban R et al. Infection and labor. V. Prevalence, microbiology, and clinical significance of intraamniotic infection in women with preterm labor and intact membranes. Am J Obstet Gynecol 1989; 161: 817-24.
14. Romero R, Yoon BH, Mazor M, Gomez R, Diamond MP, Kenney JS et al. The diagnostic and prognostic value of amniotic fluid white blood cell count, glucose, interleukin-6, and gram stain in patients with preterm labor and intact membranes. Am J Obstet Gynecol 1993; 169: 805-16.
15. Fidel PL Jr, Romero R, Wolf N, Outright J, Ramirez M, Araneda H et al. Systemic and local cytokine profiles in endotoxin-induced preterm parturition in mice. Am J Obstet Gynecol 1994; 170: 1467-75.
16. Dombroski RA, Woodard DS, Harper MJ, Gibbs RS. A rabbit model for bacteria-induced preterm pregnancy loss. Am J Obstet Gynecol 1990; 163: 1938-43.
17. Graven MG, Witkin SS, Haluska GJ, Edwards JL, Cook MJ, Novy MJ. An experimental model for intraamniotic infection and preterm labor in rhesus monkeys. Am J Obstet Gynecol 1994; 171: 1660-7.
18. Arnold RR, Brewer M, Gauthier JJ. Bactericidal activity of human lactoferrin: sensitivity of a variety of microorganisms. Infect Immun 1980; 28: 893-8.
19. Broxmeyer HE, Gentile P, Cooper S, Lu L, Juliano L, Piacibello W et al. Functional activities of acidic isoferritins and lactoferrin in vitro and in vivo. Blood Cells 1984; 10: 397-426.
20. Stuart J, Norrell S, Harrington JP. Kinetic effect of human lactoferrin on the growth of Escherichia coli 0111. Int J Biochem 1984; 16: 1043-7.
21. Visca P, Dalmastri C, Verzili D, Antonini G, Chiancone E, Valenti P. Interaction of lactoferrin with Escherichia coli cells and correlation with antibacterial activity. Med Microbiol Immunol (Berl) 1990; 179: 323-33.
22. Machnicki M, Zimecki M, Zagulski T. Lactoferrin regulates the release of tumour necrosis factor alpha and interleukin 6 in vivo. Int J Exp Pathol 1993; 74: 433-9.
23. Gomez R, Romero R, Ghezzi F, Yoon BH, Mazor M, Berry SM. The fetal inflammatory response syndrome. Am J Obstet Gynecol 1998; 179: 194-202.